Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Invested Capital (2016 - 2026)

Angiodynamics' Return on Invested Capital history spans 16 years, with the latest figure at 0.2% for Q1 2026.

  • For Q1 2026, Return on Invested Capital rose 5.0% year-over-year to 0.2%; the TTM value through Feb 2026 reached 0.2%, up 5.0%, while the annual FY2025 figure was 0.21%, 38.0% up from the prior year.
  • Return on Invested Capital reached 0.2% in Q1 2026 per ANGO's latest filing, down from 0.18% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2023 to a low of 1.2% in Q3 2024.
  • Average Return on Invested Capital over 5 years is 0.32%, with a median of 0.18% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: crashed -121bps in 2024, then skyrocketed 99bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.07% in 2022, then surged by 61bps to 0.03% in 2023, then plummeted by -3956bps to 1.15% in 2024, then surged by 84bps to 0.18% in 2025, then fell by -11bps to 0.2% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Return on Invested Capital are 0.2% (Q1 2026), 0.18% (Q4 2025), and 0.21% (Q3 2025).